BioWorld

Aug. 18, 2010

View Archived Issues

Lilly's Semagacestat Out; Gamma Secretase Still In?

Read More

NewCo News: Fabrus Forges Ahead with Therapeutic Antibody Platform

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

Financings Roundup

Read More

Eyeing Regenerative Medicine, Medtronic Acquires Osteotech

Medical device maker Medtronic Inc. staked a deeper claim in the regenerative biologics field by moving to acquire Osteotech Inc. for $6.50 per share, or $123 million. (BioWorld Today) Read More

Will Shire's Exit Be Chelsea's Gain in Hypotension Market?

Read More